PubMed laboratory research record [PMID: 26841296] PubMed record related to this compound for laboratory literature review
New weight loss medications known as GLP-1 agonists highly effective drugs that include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have been shown to reduce symptoms of the common sleep disorder, which causes temporary pauses in breathing during sleep and increases the risk of serious conditions like heart disease and diabetes
Developed by Xi'an Ebos Biotech Co., Ltd., a leading China-based manufacturer, supplier, and factory, this remarkable product is designed to deliver exceptional results
J Physiol Pharmacol 65(3):349357 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T (2018) Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats
So I think there are so many things that you can learn from this, and of course it can also inform when you look at what's actually mediating the effect and probably something around inflammation is important